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ArticleSex-Dependent QRS Guidelines for Cardiac
Resynchronization Therapy Using Computer Model
PredictionsAngela W. C. Lee,1 Declan P. O’Regan,2 Justin Gould,1 Baldeep Sidhu,1 Benjamin Sieniewicz,1 Gernot Plank,3
David R. Warriner,4 Pablo Lamata,1 Christopher A. Rinaldi,1 and Steven A. Niederer1,*
1School of Biomedical Engineering and Imaging Sciences, King’s College London, London, UK; 2MRC London Institute of Medical Sciences,
Imperial College London, London, UK; 3Department of Biophysics, Medical University of Graz, Graz, Austria; and 4Department of Cardiology,
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UKABSTRACT Cardiac resynchronization therapy (CRT) is an important treatment for heart failure. Low female enrollment in clin-
ical trials means that current CRT guidelines may be biased toward males. However, females have higher response rates at
lower QRS duration (QRSd) thresholds. Sex differences in the left ventricle (LV) size could provide an explanation for the
improved female response at lower QRSd. We aimed to test if sex differences in CRT response at lower QRSd thresholds
are explained by differences in LV size and hence predict sex-specific guidelines for CRT. We investigated the effect that LV
size sex difference has on QRSd between male and females in 1093 healthy individuals and 50 CRT patients using electrophys-
iological computer models of the heart. Simulations on the healthy mean shape models show that LV size sex difference can
account for 50–100% of the sex difference in baseline QRSd in healthy individuals. In the CRT patient cohort, model simulations
predicted female-specific guidelines for CRT, which were 9–13 ms lower than current guidelines. Sex differences in the LV size
are able to account for a significant proportion of the sex difference in QRSd and provide a mechanistic explanation for the sex
difference in CRT response. Simulations accounting for the smaller LV size in female CRT patients predict 9–13 ms lower QRSd
thresholds for female CRT guidelines.SIGNIFICANCE Left ventricle size sex difference was identified as a mechanistic cause for cardiac resynchronization
therapy (CRT) response sex differences. Computer models taking into account left ventricle size sex difference in CRT
patients were used to predict female-specific QRS duration thresholds for current guidelines. Female-specific QRS
duration thresholds 10 ms lower than current CRT guidelines, predicted using computer models, could potentially
improve treatment options for female heart failure patients.INTRODUCTION
Cardiac resynchronization therapy (CRT) aims to improve
cardiac function through resynchronizing electrical activation
in heart failure patients. CRT is recommended (or considered)
in patients with a reduced left ventricle (LV) ejection fraction
(%35%) and baseline electrical dyssynchrony measured us-
ing the QRS duration (QRSd)R130 ms (European Society
of Cardiology (ESC) guidelines) or R150 ms (American
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creativecommons.org/licenses/by/4.0/).Association (AHA) guidelines) with (or without) left bundle
branch block (LBBB) (1,2).
Clinical studies have found sex differences inCRTresponse
at different QRSd. Males with wide QRSd (R150 ms) had an
improved CRT response compared to narrower QRSd
(130–149 ms) values, whereas no such difference was re-
ported in females (3). CRT response in males with wide
QRSd (150–175ms)was also found to be equivalent to female
CRT response at lower QRSd (135–150 ms) (4).
Patients with narrow QRSd (<130 ms) are currently con-
traindicated for CRT treatment because these patients had
increased mortality rates (5). However, there is growing ev-
idence that females with narrow QRSd are at less risk of
harm from CRT and may benefit from CRT treatment at
shorter QRSd than males (3,4).Biophysical Journal 117, 2375–2381, December 17, 2019 2375
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CRT (3,4); however, relatively fewer females receive CRT.
Females have been underrepresented in CRT clinical trials,
biasing the current CRT guidelines to males, which use the
same QRSd thresholds for both sexes. This has led to interest
in sex-dependent QRSd criteria for CRT. Although quantita-
tive recommendations adapting the ACCF/AHA guidelines
have been made (6), the specific mechanism to explain the
sex difference in CRT response has not been demonstrated,
with heart size, body size and height, conduction delays, or eti-
ologyofheart failure all beingproposed aspotential causes (7).
Varma et al. (4) proposed that the prolongation of the
QRSd in LBBB patients was due to the decrease in the
myocardial conductivity in the cardiac substrate and/or
the increase in conduction path length. The conduction
path lengthens with increasing LV size, which could change
because of body size, sex, or heart failure remodeling, lead-
ing to LV dilation. Assuming that there is no sex difference
in the underlying cause for reduction in the conduction in
the cardiac substrate and, hence, response to CRT at the
same level of cardiac substrate pathology, then the sex dif-
ference in response to CRT at different QRSd would arise
from the LV size sex difference.
Females have been shown to have a smaller LV size and
QRSd in healthy (8) and patient (4) populations. The corre-
lation between the baseline healthy LV size and QRSd (8)
and the sex difference in LV size in CRT patients (4) means
that QRSd thresholds in the current CRT guidelines may be
indicative of a higher level of ventricular conduction abnor-
mality in females. This offers a mechanistic explanation for
CRT response sex differences at different QRSd (3).
Our hypothesis is that LV size is a significant contributor
to CRT response sex differences at different QRSd. We
tested this hypothesis using computer models of the heart
in healthy and patient cases to isolate the LV size effects
on QRSd. Initially, we confirmed that males and females
have different-sized hearts and that LV size correlates with
predicted QRSd. We then quantified the degree to which
LV size explains sex difference in QRSd. Finally, QRSd rec-
ommendations in the current guidelines for CRT, which
were primarily determined from males, were calibrated us-
ing computer models to predict the female QRSd threshold
for CRT treatment, taking into account female LV size.METHODS
Data set: healthy cases
Cardiac magnetic resonance (CMR) of 1093 healthy individuals with no
known cardiovascular diseases were acquired using a balanced steady-state
free precession sequence (voxel size: 1.25  1.25  2 mm). Images were
collected with written informed consent at Hammersmith Hospital (Lon-
don, UK) with study protocols approved by local ethics committee as
part of UK Digital Heart Project (https://digital-heart.org/). A sex-specific
cardiac atlas from these images was derived (9). Mean shape models of2376 Biophysical Journal 117, 2375–2381, December 17, 2019the LV were obtained by averaging the male (n ¼ 493) and female (n ¼
600) segmentations (9).Data set: CRT patients
CMR of 50 CRT patients were acquired with electrocardiogram-gated free-
breathing steady-state free precession sequence (median voxel size: 0.89 
0.89  1 mm) as standard care, before CRT implantation. CRT inclusion
criteria were as follows: New York Heart Association (NYHA) class
II–IV, LV ejection fraction <35%, QRSd >130 ms, and optimal medical
therapy. Data were collected with written informed consent at St Thomas’
Hospital (London, UK) or Sheffield Teaching Hospital (Sheffield, UK) with
study protocols approved by local ethics committees. The patient popula-
tion was primarily elderly (69.3 5 11.2 years), males (78%) with LBBB
(92%), and with 46% ischemic etiology (10). In the 50 patient cases, the
LV was semiautomatically segmented from CMR images by two observers.
An automatic method was used to construct the three-dimensional models,
and an averaged consensus model was used (10) (https://doi.org/10.6084/
m9.figshare.5853948).Electrophysiology simulations
QRSd sex differences in healthy individuals and CRT patients were
explored by simulating the LV electrical activation on the healthy mean
shape and CRT patient models with an eikonal model using the Cardiac
Arrhythmia Research Package (11).
A rule-based fast endocardial conduction model was used to simulate
the electrical propagation of the left ventricle. Experimental studies
have shown the conduction velocity (CV) in the myocardium varies
across the ventricles with increased conduction in the endocardial layer
(12). The heterogeneous cardiac substrate was modeled with a 1-mm
thick layer on the endocardial surface, assumed to have sixfold increased
CV in comparison to the bulk myocardium (Fig. 1 a). We have chosen to
use eikonal equations that approximate the electrical activation of the
heart (13). These equations allow for efficient simulations of activation
patterns, allowing for larger numbers of simulations to be performed
cost effectively.
The electrical activation of the ventricles was assumed to flow primarily
along the myofibers, with the CV across the transverse fiber directions as-
signed to be 40% of the fiber direction CV. In normal human hearts, no
sex differences in the gross fiber anatomy has been found (14), and fiber
alignment has been shown to remain consistent in patients with hypertrophy
or clinical heart failure (15). Although a sex difference in the fiber orienta-
tion could manifest in CRT patient populations, to date, we have no evi-
dence to suggest that this happens. The LV fiber directions were
therefore assumed to be consistent between male and female hearts and
modeled using Bayer’s rule-based methods (16).
Ischemia was not accounted for in the models. Assuming that scarred
regions have zero CV and the scar is not completely transmural, the elec-
trical activation travels around the region of scar and thus has little effect
on the QRSd. Although scarred regions have been found to have signif-
icant effects on the CRT response of patients, in this manuscript, our
models are used to predict the QRSd sex difference rather than the
CRT response of each patient. The QRSd sex differences under intrinsic
and pathological electrical activation was investigated using mean shape
models of healthy individuals and CRT patient models. To simulate non-
LBBB, the ventricle was activated in the apical third of the endocardium
(Fig. 1 b), where ex vivo studies have found a greater concentration of
Purkinje fiber branching in healthy human hearts (17). LBBB was
approximated by right ventricle (RV)-apex stimulation (Fig. 1 c) as
studies have found there is no significant difference in the total LV acti-
vation time between RV-apex pacing and LBBB (18). In the model sim-
ulations, QRSd was approximated as the time taken for total LVactivation
time.
FIGURE 1 Mean shape model simulations. (a)
Fast endocardial conduction model was used to
simulate the electrical activity of the left ventricle.
The endocardial layer (blue) had a sixfold
increased CV compared to bulk myocardium
(red). The electrical activation was then simulated
for (b) intrinsic activation, in which the lower third
of the endocardium was initially activated and (c)
RV pacing was a surrogate for LBBB. To see this
figure in color, go online.
Sex-Dependent QRSd for CRT Using ModelsTo predict the sex difference in the QRSd, we first estimated the CV in
the male hearts that would result in a desired QRSd. This inferred CV
was then used to predict how LV size sex difference affected the QRSd us-
ing female heart models in healthy and patient populations.RESULTS
LV size sex difference
The LV size for each model was quantified by LV mass and
LVend diastolic volume (LVEDV). These LV size measures
were determined for each mean shape model (male, female)
and patient case (Table 1). LV mass was calculated by multi-
plying the volume of the mesh with the myocardial density
(1.05 g/mL). We confirmed that the LV mass and LVEDV
for healthy females was substantially smaller than males,
consistent with literature (8). Our values for normal LV
mass and LVEDV were reduced and increased outside of
the range from literature values, respectively (8). This
discrepancy likely is due to Lorenz et al. (8) including the
papillary muscles in the LVmass, whereas we have included
the papillary muscle in the LVEDV.
We also confirmed the LV size sex difference was present
in the CRT patient cohort, in which mean LV mass and
LVEDV was statistically significantly smaller for females
than for males (193 g and 170 mL vs 252 g and 238 mL,
p < 0.05), consistent with literature (4).Effect of LV size on the QRSd
Although LV size is a crucial factor in the QRSd, the loca-
tion of the onset of electrical activation and the speed of theTABLE 1 LV Size Measures for the Mean Shape Models and the Pa
Compared Against Literature Values
Models or References Patient Type
L
Male
Mean shape models No HFa 138.9
Patient models (n ¼ 50) CRT 251.5
Lorenz et al. (8) No HF 1785 31
Varma et al. (4) CRT 2735 78
aNo HF, No heart failure or known cardiovascular diseases.spread of electrical activation can also have an effect. Com-
puter models allowed for the isolation and quantification of
the effect of LV size on the QRSd across sexes for healthy
and CRT patient cases (Fig. 2). In Fig. 3, the relationship be-
tween LV size and QRSd for each CRT patient case was
plotted. The positive relationship between the QRSd and
the LV size was confirmed in the CRT patient cohort, with
Spearman correlation coefficients of LVEDV 0.21 and LV
mass 0.36. Although these values are not consistent with
literature values of 0.41 and 0.44, respectively (4), a similar
trend of a positive correlation was observed, with the differ-
ences possibly due to the differences in enrollment criteria
for the patient cohort, with the patient cohort used in this
study having less strict enrollment criteria (NYHA class
II–IV, ischemia allowed (46% of patients)) in comparison
with Varma et al. (4) (NYHA III and nonischemic cardiomy-
opathy with true LBBB). The model predictions provide
support for the collection of larger data sets of female pa-
tients with narrow QRSd. This would confirm the biophys-
ical and statistical predictions (4) and provide more
information to refine CRT patient selection.LV size and QRSd sex differences
Model simulations were used to identify if LV size sex dif-
ference could explain the QRSd sex difference observed in
the healthy population. The CV for the mean male shape
model needed to approximate an average male QRSd
(90 ms (19) or 100 ms (20)) was applied to the mean female
shape model. The LV size sex difference resulted in a female
QRSd that was 4 ms lower, consistent with literature valuestient Cases Differentiated into Male and Female Cohorts
V Mass (g) LVEDV (mL)
Female Male Female
114.7 158.1 124.9
192.6 238.1 169.6
1255 26 1365 30 965 23
1735 58 2615 109 1655 67
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FIGURE 2 Patient model simulations. Intrinsic
activation (non-LBBB approximation) was simu-
lated for the male patient models (n ¼ 39) to
achieve a total activation time of 120 ms. The
mean male CV was then applied to each of the fe-
male patient models (red, n ¼ 11) to determine the
equivalent female total activation times. To see this
figure in color, go online.
Lee et al.of 4–8 ms reduction in QRSd values for females (90–86 ms
(19) and 100–92 ms (20)).Calibration of QRSd for CRT patients on the basis
of LV size sex difference
Female-specific QRSd thresholds for the CRT guidelines
were estimated using the CRT patient models. LV electrical
activation was simulated with RV-apex pacing (LBBB
approximation) and intrinsic stimulation (non-LBBB
approximation) for the male patients (n ¼ 39). The CV
required in each male patient to attain QRSd of 120, 130,
and 150 ms was determined. The mean CV for males was
then used in the female patients (n ¼ 11) to predict the fe-
male-specific QRSd guidelines for LBBB and non-LBBB
conditions (Table 2).DISCUSSION
We used computational models to isolate the effect of LV
size sex difference in QRSd in healthy individuals and
CRT patients. Our simulations predicted that the LV size
sex difference could explain 50–100% of the QRSd sex dif-
ference in healthy individuals. The simulations on the pa-
tient models predicted that current CRT guidelines should
be reduced by 10 ms when applied to females.2378 Biophysical Journal 117, 2375–2381, December 17, 2019The role of LV size in QRSd sex difference
Literature studies on individuals without heart failure have
shown that males have a larger LV and QRSd, with average
healthy male QRSd 4–8 ms higher than females (19,20).
Our simulations with the mean shape models were consis-
tent with literature, predicting a 4 ms shorter QRSd for fe-
males. This means our simulations predict that LV size
sex difference can account for 50–100% of the QRSd sex
difference.
In this study, we investigated the impact of size on QRSd.
Other factors, including septal slowing, functional block,
infarct size, and fast endocardial conduction ratio, could
also impact QRSd. However, we have shown in a prospec-
tive clinical and simulation study (1) that these factors
have a limited impact on the accuracy of simulating the
electrical activation of the left ventricle and so were not
considered in this study.Clinical relevance
CRT response sex differences have been found in clinical
studies, with females having improved CRT response while
being at less risk of harm at lower QRSd (3,4,6), leading to
interest in sex-dependent QRSd guidelines for CRT. Consis-
tent with our model predictions that the QRSd could beFIGURE 3 LV size measures in relation to the
QRSd for the 50 patient cases. The mean LV size
measures for the male (blue stars) and female
(red circles) cohorts are shown as solid and dashed
lines, respectively. To see this figure in color, go
online.
TABLE 2 Computer Models of theMale Patient CasesWere Used to Simulate the Electrical Activation of the LVwith Intrinsic and RV
Pacing
Male QRSd (ms)
Intrinsic Stimulation (Non-LBBB Approximation) RV Pacing (LBBB Approximation)
Mean Male CV (m/s) Female QRSd (ms) (n ¼ 11) Mean Male CV (m/s) Female QRSd (ms) (n ¼ 11)
120 ms 0.49 111.05 10.8 0.65 109.15 8.9
130 ms 0.45 120.25 11.7 0.60 118.35 9.7
150 ms 0.39 138.55 13.5 0.52 136.85 11.2
The CV needed to predict the male QRSd of 120, 130, and 150 ms were evaluated in each case. The mean male CV was applied to the female patient cases to
predict the equivalent female QRSd values.
Sex-Dependent QRSd for CRT Using Modelsreduced to 137 ms for female patients with LBBB and mild
heart failure, Zusterzeel et al. (6) proposed adapting the
ACCF/AHA guidelines (1), reducing the QRSd threshold
from R150 to R130 ms.
For moderate and severe forms of heart failure with
LBBB, Zusterzeel et al. (6) proposed no sex difference, rec-
ommending lowering the QRSd (R150 ms) for male and fe-
male patients to be in line with ESC guidelines (QRSd
R130 ms). However, CRT response sex differences have
also been found in moderate to severe cases of heart failure.
Our models predict that the equivalent female QRSd thresh-
olds for current guidelines were 9–13 ms lower than males
for patients with non-LBBB and LBBB conditions with
mild to severe heart failure (Table 3).
Our model simulations predict that CRT in females may
be effective at QRSd <130 ms and that narrow QRSd
(<130 ms) should be calibrated to <120 ms in females
for the ESC guidelines (2). This is consistent with studies
on CRTwith narrow QRSd, in which unlike males, females
with narrow QRSd did not have increased mortality rates
with CRT (5). A recent study also found that a smaller LV
size was associated with improved CRT response in patients
with QRSd <130 ms (21), supporting lower narrow QRSd
threshold for females who generally have smaller LV sizes.
Our models predict that a prolonged QRSd of 150 ms in
males was equivalent to a QRSd of 137–138 ms in females.
This was consistent with the Varma et al. study in
which CRT response in males with wide QRSd rangeTABLE 3 Predicted Female QRSd Guidelines for CRT Recommend
Guidelines QRSd (ms) QRS Morphology EFa ICMb
ESC 2016 (2) >130 LBBB <35%
>130 non-LBBB <35%
<130 <35%
ACCF/AHA 2013 (1) >150 LBBB <35%
>150 non-LBBB <35%
120–149 LBBB <35%
120–149 non-LBBB <35%
>150 non-LBBB <35%
>150 LBBB <30% ICM
<150 non-LBBB <35%
aEF, Ejection fraction.
bICM, Ischemic Cardiomyopathy.
cNYHA Class, New York Heart Association Functional Classification.
dCOR, class of recommendation.(150–175 ms) was equivalent to a shorter QRSd range
(135–150 ms) for females (4). This was also consistent
with studies that found distinct improvements in male
CRT response as QRSd lengthens past 150 ms, whereas fe-
males have the same positive CRT responses with QRSdR
or <150 ms (3). Our models predict that a significant part of
CRT response sex differences can be explained by smaller
female heart sizes.
Our simulation results explain the sex difference in CRT
treatment numbers (25% female) (22) as a subgroup of fe-
male patients who may benefit from CRT yet have QRSd
10 ms less than the current QRSd thresholds are presently
not recommended for CRT. Incorporating female-specific
QRSd thresholds into the guidelines could help clinicians
in identifying females that could respond positively to CRT.Other factors influencing LV size
In this manuscript, we have shown that LV size sex differ-
ence affects the QRSd, a predictive measure for CRT
response. LV size is influenced by factors other than sex,
such as lifestyle choices, height, disease, race, and aging.
Linde et al. recently concluded that in addition to QRSd,
height also independently predicts CRT response, so
height-corrected QRSd thresholds should be further
explored (7). Smoking and diabetes have also been associ-
ated with an increase in LV mass. The impact of adult aging
on the LV size is less clear, with studies having found eitherations Calibrated with LV Size
NYHAc Class CORd Recommendation Female QRSd (ms)
I Recommend CRT >118
II a Consider CRT >120
III Contraindicated <120
II, III, IV I Recommend CRT >137
II II a Can be useful >138
II, III, IV II a Can be useful 109–136
III, IV II b May be considered 111–137
II II b May be considered >138
II b May be considered >137
I or II III Contraindicated <138
Biophysical Journal 117, 2375–2381, December 17, 2019 2379
Lee et al.no change (19,20) or an increase in the LV mass. There has
also been debate into whether racial characteristics (Afri-
can/Caucasian) effect the size of the LV with studies finding
increased LV size for African subjects. Therefore, in addi-
tion to sex-dependent QRS guidelines for CRT, other patient
subgroups may also benefit from distinct QRSd guidelines.Limitations
In this study, we have assumed that CRT response is depen-
dent on a dyssynchronous electrical substrate. This assump-
tion is based on the use of QRSd in current CRT inclusion
criteria (1,2) and that baseline QRSd and change in QRSd
with pacing correlates with the response to CRT (3). How-
ever, QRSd is also a surrogate for activation pattern and ma-
terial properties, which may be more predictive of CRT
response. Assuming that this is the case, we have predicted
new thresholds for CRT inclusion criteria, calibrating for
differences in heart size between males and females. How-
ever, we have not tested these predictions, and the difference
in CRT response between men and woman could be due to
different as yet to be identified mechanisms.
We have assumed that the primary reason for the QRSd
sex difference is because of the sex difference in the LV
size and that the CV is consistent across genders. The CV
is dependent on ionic channels in the cardiac cells. Although
studies have found sex differences in cardiac ionic channels,
these changes are primarily seen in repolarization channels
of the heart (23) and do not affect the CV during the QRS
complex.
However, CV in the cardiac substrate could also be
affected by fibrosis, scar, and reduced intercellular coupling.
Sex-dependent differences have been found in fibrosis, with
fibrosis being less prevalent in female heart failure patients.
It has been suggested that estrogen may be a modulating
factor on the underlying pathways for fibrosis, which
changes post-menopause as estrogen levels decline (24).
In macroscopic modeling terms, fibrosis would result in
reduced CV in the myocardium and hence a longer QRSd.
This is represented in our models in Table 2. The CV was
set to be constant between the sexes, and we are assuming
that at the same level of fibrosis (or other cause of decrease
in CV), the response to CRTwould be the same regardless of
gender.
On the other hand, if the underlying cause of response to
CRT at prolonged QRSd is not dependent on the fibrosis,
then the heightened male prevalence for fibrosis would
only exacerbate the issue in which female patients would
have a higher CV in comparison to male patients, leading
to a further decrease in the female QRSd threshold. In addi-
tion to this, the sex difference in the prevalence of fibrosis in
patients could also potentially be a cause for the lower
enrollment number of female patients in CRT.
In this study, we investigated the impact of size on QRSd.
Other factors, including septal slowing, functional block,2380 Biophysical Journal 117, 2375–2381, December 17, 2019infarct size, fast endocardial conduction, could also impact
QRSd. We have shown in a prospective clinical and simula-
tion study (13) that these factors have a limited impact on
the accuracy of simulating the electrical activation of the
left ventricle and so were not considered in this study.
In the models, it was assumed that male and female hearts
followed the same fiber orientation rules as described by
Bayer et al (longitudinal fiber orientation: þ40 to 50
across the myocardial wall) (16) as in normal human hearts,
gross fiber anatomy is equivalent between sexes (14), and no
changes in fiber angle have been reported in hypotrophy or
heart failure hearts (15). However, these measurements are
made with a finite precision, and small differences in fiber
angle could affect simulations results. We ran additional
simulations to test the effect of perturbing the fiber angles
by510% in the mean shape models of the male or female
hearts. The CV was fitted to a QRSd of 100 ms for the male
models. Fiber angle perturbations of 510% was found to
result in 53 ms change in the QRSd in the female heart.
Although this is only a 3% difference in the QRSd, this
difference is in the same order of magnitude as the total dif-
ference in the mean QRSd between normal male and female
hearts (4–8 ms). This makes it possible that subtle differ-
ences in fiber angle between male and female hearts may
play a role in determining QRSd. To date, there is no evi-
dence that indicates that a sex difference is present, but sys-
temic or gender-specific differences in fiber orientation
disease response may affect activation time and pattern.
In the model simulations, we have assumed a fixed
anisotropy ratio of 0.4, in which the CV transverse to
the fibers was 40% of the CV along the fibers (13). We
tested this assumption in the healthy male and female
models by perturbing the anisotropy ratio by 510% and
found that this resulted in only minor differences in the
QRSd (<0.1 ms).
In contrast to previous studies using bidomain or mono-
domain simulations, an eikonal model was used to simulate
the spread of the electrical activation in the LV to minimize
the computational costs. In a previous study, the accuracy of
the activation times for the eikonal model was within 1% of
the reaction-eikonal model (13), which has been shown to
be comparable to the bidomain models in simulating electri-
cal activation of the heart (25).CONCLUSION
In this study, we used computer models to show that the
sex difference in the QRSd can be explained with LV
size sex difference. Computer models of CRT patients
divided into male and female cohorts were used to identify
the QRSd threshold values for the female patient popula-
tion for CRT recommendations. Sex-dependent guidelines
for CRT could help clinicians in better identifying female
heart failure patients who could potentially benefit from
CRT.
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